TipRanks
Sosei Group Corporation (JP:4565)
:4565
Japanese Market
4565
Sosei Group
RESEARCH TOOLSreports
Want to see JP:4565 full AI Analyst Report?

Sosei Group (4565) Stock News & Sentiment

3 Followers
Nxera Pharma advances APAC expansion and partnered pipeline with new deals and milestones
Premium
Company Announcements
Nxera Pharma advances APAC expansion and partnered pipeline with new deals and milestones
2d ago
Nxera Pharma Returns to Profit and Confirms Full-Year Outlook
Premium
Company Announcements
Nxera Pharma Returns to Profit and Confirms Full-Year Outlook
2d ago
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4d ago
Nxera Pharma Licenses Idorsia’s Fabry Drug Lucerastat for Key Asia Pacific Markets
Premium
Company Announcements
Nxera Pharma Licenses Idorsia’s Fabry Drug Lucerastat for Key Asia Pacific Markets
4d ago
Nxera Pharma Seeks South Korean Approval for DMD Drug Vamorolone
Premium
Company Announcements
Nxera Pharma Seeks South Korean Approval for DMD Drug Vamorolone
10d ago
Nxera Pharma Ties Executive Stock Options to Aggressive Long-Term Share Price Hurdles
Premium
Company Announcements
Nxera Pharma Ties Executive Stock Options to Aggressive Long-Term Share Price Hurdles
12d ago
Nxera Strikes Synmosa Deal to Expand Insomnia Drug QUVIVIQ Across Asia-Pacific
Premium
Company Announcements
Nxera Strikes Synmosa Deal to Expand Insomnia Drug QUVIVIQ Across Asia-Pacific
18d ago
More JP:4565 News >

4565 News on the Web

Nxera Pharma advances APAC expansion and partnered pipeline with new deals and milestones
TipRanks News
Bullish
Nxera Pharma Returns to Profit and Confirms Full-Year Outlook
TipRanks News
Bullish
Nxera Pharma Licenses Idorsia’s Fabry Drug Lucerastat for Key Asia Pacific Markets
TipRanks News
Bullish
Nxera Pharma Ties Executive Stock Options to Aggressive Long-Term Share Price Hurdles
TipRanks News
Bullish
Q2 2026 Nxera Pharma Co Ltd Earnings Presentation (Japanese) Transcript
GuruFocus News
Neutral
Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug
TipRanks News
Bullish
Nxera Pharma Secures Fourth AbbVie Milestone in Neurology Collaboration
TipRanks News
Bullish
Nxera Pharma Joins OpenFold AI Consortium to Boost GPCR Drug Discovery
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
JP:4565
Sector Average
Media Buzz
This Week4 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4565’s Media Buzz Sentiment?
4 articles about JP:4565 were published this week. In an average week, 0.75 articles are published.
    What is JP:4565’s weekly average amount of articles?
    In an average week, 0.75 articles about JP:4565 are published.
      What is JP:4565’s News Sentiment?
      100% of articles about JP:4565 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week